WearOptimo Revenue and Competitors
Estimated Revenue & Valuation
- WearOptimo's total funding is $12M.
Employee Data
- WearOptimo has 23 Employees.
- WearOptimo grew their employee count by -18% last year.
WearOptimo's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO and Executive Director | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Executive Officer | Reveal Email/Phone |
5 | Advanced Manufacturing Manager | Reveal Email/Phone |
6 | Manager - People Experience | Reveal Email/Phone |
7 | Data Scientist | Reveal Email/Phone |
8 | Senior Data Scientist | Reveal Email/Phone |
9 | Mechanical Engineer | Reveal Email/Phone |
10 | Engineering Technician | Reveal Email/Phone |
WearOptimo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 23 | -18% | $11.9M | N/A |
#2 | N/A | 36 | 6% | $15.8M | N/A |
What Is WearOptimo?
Founded in 2018 by award-winning biomedical engineer, scientist and business builder, Mark Kendall, WearOptimo is a global leader in the field of microwearable technology. With a vision to shift the focus of healthcare to early identification and intervention, WearOptimo’s sensors track real-time data from the body’s biomarkers to detect conditions ranging from dehydration to heart attacks. Clinical trials of its first sensor have commenced in 2023. WearOptimo has strategic and investment support from the Australian National University and federal and state governments, with a further strategic and investment partnership with Aspen Medical.
keywords:N/A$12M
Total Funding
23
Number of Employees
N/A
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 26 | N/A | N/A |
#2 | $18.3M | 42 | -9% | N/A |
#3 | N/A | 53 | 20% | N/A |
#4 | $9M | 58 | -16% | N/A |
#5 | N/A | 111 | 88% | N/A |